Although both antigens were not detected in several cases, we found that loss of MLH1 expression was observed in the majority of MSI+ tumours (22/36), whereas being significantly less frequent in microsatellite-stable tumours (4/51, p < 0.01). The gene discussed is MLH1; the disease is neoplasm.